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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not “Are
foot orthoses effective at reducing pain in adults with foot osteoarthritis?”
STUDY DESIGN: A review of two randomized controlled trials and one case series from peerreviewed journals published between 2010 and 2016.
DATA SOURCES: Two randomized controlled trials and one case series were found using
PubMed.
OUTCOME MEASURED: Reduction of the subject’s foot pain was the patient-oriented
outcome measured in each of these three articles. The subject’s pain was scored on a Likert scale
and evaluated at baseline and at 12 weeks to assess their response to foot orthoses.
RESULTS: The first randomized controlled trial analyzed determined that prefabricated foot
orthoses improved subject Foot Health Status Questionnaire (FHSQ) pain domain scores similar
to rocker-sole footwear in patients with 1st metatarsophalangeal joint osteoarthritis (Menz HB,
Auhl M, Tan JM, Levinger P, Roddy E, Munteanu SE. Arthritis Care Res. 2016;68(5):581-589. doi:
10.1002/acr.22750 [doi]). A case series determined that custom-made semi-rigid foot orthoses
with or without carbon fiber foot plates reduced average pain scores in patients with midfoot
osteoarthritis (Ibuki A, Cornoiu A, Clarke A, et al. Prosthet Orthot Int. 2010;34(4):461-471. doi:
10.3109/03093646.2010.503672.). The final randomized controlled trial examined found that
functional foot orthoses (FFO) did reduce subject “average pain in the month” questionnaire
scores similar to sham orthoses in adults with midfoot osteoarthritis. However, the study had a
wide estimate of treatment effect making it difficult to determine if there was a difference
between interventions (Chapman GJ, Halstead J, Redmond AC. Gait Posture. 2016;49:235-240.
doi: 10.1016/j.gaitpost.2016.07.012.).
CONCLUSIONS: The two randomized controlled trials and one case series in this review
showed some data to suggest foot orthoses are effective at reducing pain in adults with foot
osteoarthritis. However, future randomized controlled trials are needed to determine if foot
orthoses are superior to other treatment options for foot osteoarthritis.
KEY WORDS: foot orthoses, osteoarthritis
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INTRODUCTION
Osteoarthritis (OA) is the most common type of arthritis, where all structures of the joint
have undergone pathologic change leading to joint failure. OA commonly affects the cervical
and lumbosacral spine, proximal and distal interphalangeal joints of the hands, carpometacarpal
joint of the thumb, as well as joints of the hip, knee, and feet.1 Within the foot, the first
metatarsophalangeal (MTP) joint is most commonly affected, followed by the second
cuneometatarsal and talonavicular joints.2
It is estimated 22.7% (54.4 million) of adults in the United States have doctor diagnosed
arthritis, with significantly higher age-adjusted prevalence in women (23.5%) than in men
(18.1%).3 About 43.5% (23.7 million) of 54.4 million adults with doctor-diagnosed arthritis have
limitations in their usual activities due to their arthritis.3 As the US population continues to age,
the prevalence of doctor-diagnosed arthritis is expected to increase. By the year 2040, an
estimated 78.4 million adults aged 18 years and older will have doctor-diagnosed arthritis.3 Foot
pain affects one in four people aged over 75 years, two-thirds of whom have related locomotor
disability.2 Symptomatic foot OA affects 17% of adults aged 50 years and over.2
In 2013, total medical care expenditures attributed to arthritis and earning losses were
303.5 billion, or 1% of the 2013 US gross domestic product.4 In that year, OA accounted for
$16.5 billion (4.3%) of the combined costs for all hospitalizations, second to septicemia.5 OA
was the leading cause (46%) of hospitalizations among all arthritis diagnoses and was diagnosed
in 23.7 million healthcare visits in 2013.6 Nearly 3 million hospital stays in 2013 had an OA
diagnosis.6
OA is a disease caused by hyaline articular cartilage loss, which is accompanied by
increasing thickness and sclerosis of the subchondral bony plate, outgrowth of osteophytes at the
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joint margin, stretching of the articular capsule, variable degrees of synovitis, and weakness of
muscles bridging the joint.1 Joint vulnerability and joint loading are the two major factors
contributing to the development of OA, with the cartilage being the primary target tissue for
disease.1
Patients with OA experience a slow onset of pain affecting one or a few joints at a time that
is increased with joint use and relieved with rest.7 Joint stiffness is short lived (<30 minutes) and
is early morning or inactivity related.7 Other features include mild swelling and absence of
constitutional symptoms.7 Signs of OA include: swelling, deformity, muscle wasting, joint line
tenderness, crepitus, and reduced range of motion.7 First MTP joint OA is usually bilateral, and
when symptomatic leads to localized big toe pain on standing and during ambulation. 7 Bony
enlargement of the first MTP joint, hallux valgus, hallux rigidus, and cross-over toes are
common deformities, frequently leading to the development of a complicating bursa with
additional fibrous tissue reactions on the medial aspect of the first MTP joint.7
Management of foot OA generally begins with conservative interventions, including
analgesic or anti-inflammatory medications, intra-articular injections, physical therapy, footwear
modifications, foot orthoses, and surgery.2,8
There is currently no cure for foot OA and there are few randomized controlled trials
demonstrating efficacy of one treatment vs. another. Foot orthoses may show to be an effective
intervention for reducing pain in adults with foot osteoarthritis.
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OBJECTIVE
The objective of this selective EBM review is to determine whether or not “Are foot
orthoses effective at reducing pain in adults with foot osteoarthritis?”
METHODS
Three studies on the use of foot orthoses as treatment for foot osteoarthritis in adults were
selected for analysis. Menz et al. compared prefabricated foot orthoses vs. rocker-sole footwear
in adults with 1st MTP OA, Ibuki et al. compared custom-made semi-rigid foot orthoses with or
without carbon fiber foot plates in patients with midfoot OA, and Chapman et al. compared
functional foot orthoses (FFO) vs. sham foot orthoses in adults with midfoot OA. Each study
looked at the outcome of subject pain reduction.
Data sources were searched using key words “foot orthoses” and “osteoarthritis”. All
articles were published in English and in peer-reviewed journals. Articles were searched via
PubMed and selected based on their relevance to the clinical question and that the outcome of the
study mattered to the patient (POEM). Articles were included if they were clinical studies and
randomized controlled trials published after 2008 on human subjects, in English language.
Clinical studies and randomized controlled trials published in 2008 or earlier on non-human
subjects, in non-English language were excluded. Statistics used and reported include: mean
change from baseline, p-value, confidence interval (CI), relative risk (RR), and number needed
to harm (NNH). Menz et al. and Chapman et al. are both randomized controlled trials, while
Ibuki et al. is a case series. Table 1 illustrates the various characteristics of the studies analyzed
during this selective EBM review.
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Table 1. Demographics and characteristics of included studies.8-10
Study
Menz8
(2016)

Type

# Pts

Age
(yrs)

Inclusion
Criteria

Exclusion
Criteria

W/D

Intervention

RCT

102

Orthoses
Group
57.1 ±
11.1
years old

Age ≥ 18 years,
report 1st MTP
joint: pain for at
least 12 weeks,
<64°of
dorsiflexion
ROM, TTP of
the dorsal aspect
of the joint. Be
able to walk >50
meters without
assistance,
abstain from
additional
interventions
(PT, other
orthoses, shoe
modification,
injections, or
surgery) and d/c
pain medication
14 days prior to
and for the
duration of the
study.

Pregnancy,
previous 1st MTP
joint surgery,
significant 1st MTP
deformity, or
intraarticular
injection (in the
past 6 mo) of the
1st MTP joint.
Presence of other
foot or ankle
condition, systemic
inflammatory
condition,
connective tissue
disease, cognitive
impairment, or hx
of recurrent falls (≥
2 in the last year),
currently wearing
contoured foot
orthoses,
specialized
footwear or
footwear that
would not
accommodate foot
orthoses.
Presence of other
symptomatic
conditions of feet
or ankles unrelated
to midfoot OA,
previously received
the same orthotic
tx as prescribed in
the study
Hx of
inflammatory joint
disease,
neuropathy, or
stress fractures, LE
surgery in the last
year, existing use
of OTC or Rx foot
orthoses

Orthoses
Group –
5

Prefabricated
foot orthoses
vs. rockersole footwear

Footwear
Group
56.5 ±
11.1
years old

Ibuki 9
(2010)

Case
Series

57

Range –
37-81
years old
Mean –
63.95
years old

Chapman10
(2016)

RCT

37

Mean –
58.4
years old

Dx of midfoot
OA with
radiographic
evidence,
midfoot pain

Age ≥ 18 years,
Dx of midfoot
OA with
radiographic
evidence,
midfoot pain ≥ 3
months

Footwear
Group –
5
Total 10

0

Foot orthoses
with and
without rigid
carbon fiber
foot plates

4

Functional
foot orthoses
vs. sham foot
orthoses

4
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OUTCOME MEASURED
Reduction of the subject’s foot pain was the patient-oriented outcome measured in each
of these three articles. The subject’s pain was scored on a Likert scale and evaluated at baseline
and at 12 weeks to assess their response to foot orthoses.
In the study conducted by Menz et al., the outcome measured was the subject’s foot pain
domain of the Foot Health Status Questionnaire (FHSQ), which is a foot specific, health related
quality of life outcome measure.8 Questions within each domain are scored ranging from 0
indicating very poor foot health to 100 indicating optimum foot health.8 Ibuki et al. developed
patient evaluation questionnaires where patients rated their average level of pain, from 0
indicating ‘no pain’ to 10 indicating ‘worst pain’.9 Chapman et al. assessed subject’s average
pain in the last month using an 11-point numeric rating scale scored from ‘no pain’ to ‘pain as
bad as you can imagine’.10
RESULTS
This selective EBM review utilized two randomized controlled trials and one case series
to determine the efficacy of foot orthoses at reducing pain in adults with foot osteoarthritis. All
three studies took place in outpatient settings.8-10
The first study conducted by Menz et al. was a parallel-group randomized controlled trial
comparing prefabricated foot orthoses vs. commercially available rocker-sole footwear for the
treatment of 1st MTP OA.8 Participants were recruited via radio, newspaper, and social media
advertisements.8 To be included in the study, participants must be: ≥ 18 years of age, report 1st
MTP joint pain for at least 12 weeks, have <64°of dorsiflexion ROM of the 1st MTP joint, have
pain with palpation to the dorsal aspect of the 1st MTP joint, be able to walk >50 meters without
assistance, abstain from additional interventions (PT, other orthoses, shoe modification,
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injections, or surgery) during the study and willingly discontinue pain medication 14 days prior
to and for the duration of the study.8 Participants were excluded if they were pregnant, had
previous 1st MTP joint surgery, significant 1st MTP deformity, or had intraarticular injection (in
the past 6 mo) of the 1st MTP joint.8 Researchers also excluded participants if they were
diagnosed with another foot or ankle condition, a systemic inflammatory conditions, a
connective tissue disease, cognitive impairment, had history of recurrent falls (≥ 2 in the last
year), currently wearing contoured foot orthoses, specialized footwear or footwear that would not
accommodate foot orthoses.8 Of the 326 assessed for eligibility, 102 participants were
randomized using permuted block randomization to either the prefabricated foot orthoses group
(n = 52) or the rocker-sole footwear group (n = 50).8 In the foot orthoses group, one participant
withdrew as they could not tolerate the orthoses and four were lost to follow-up giving a
completion rate of 90%.8 In the rocker-sole footwear group, four withdrew consent after
randomization leaving forty-six participants who received the allocated intervention.8 Of these
subjects, three were lost to follow up and two could not tolerate the footwear giving a completion
rate of 89%.8 The primary outcome measure was the foot pain domain of FHSQ measured at
baseline, 4, 8, and 12 weeks.8 In order to compare this RCT to other studies, this review focuses
on subject FHSQ pain domain score at baseline and 12 weeks. Table 2 illustrates improvement in
subject baseline mean score to 12-week follow up in both the functional foot orthoses group and
rocker-sole footwear group. A p-value of 0.477 indicates there is no significant difference
between the two groups.8
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Table 2. Subject FHSQ pain domain (0-100) score in Menz et al.8
Orthoses Group

Rocker-Sole Footwear Group

(n = 52)

(n = 46)

Baseline Mean ± (SD)

56.7 ± (19.2)

51.5 ± (20.3)

12 weeks Mean ± (SD)

73.6 ± (16.8)

73.7 ± (14.8)

Mean change from baseline (Calculated)

16.9

22.2

P-value

0.477

Table 3 demonstrates the most commonly reported adverse events during the Menz et al.
study. Participants in the rocker-sole footwear group were more likely to report new onset low
back pain during the study than the functional foot orthoses group.8 A p-value of 0.048 indicates
statistically significant difference between the two interventions. Researchers calculated NNH is
8 (3.9, 71.0) with 95% CI meaning that for every eight patients treated with rocker-sole
footwear, one more patient would experience low back pain than if they were treated with
functional foot orthoses.8 Adherence varied markedly between the two groups. Researchers
found that the footwear group wore their shoes for an average of 287 hours in total throughout
the 12-week study period compared to the 448 hours for the orthoses group.8
Table 3. Adverse events reported during Menz et al. study.8
Rocker-Sole
Adverse Event

Orthoses Group

NNH
Footwear Group

Number (%)

Relative Risk (95% CI)

P Value

(n = 52)

(95% CI)
(n = 46)

New Low Back Pain

2 (3.8)

8 (17.4)

4.52 (1.01, 20.22)

0.048

Experienced Fall

5 (11.1)

4 (10.3)

0.92 (0.27, 3.20)

0.900

Blisters

2 (3.8)

3 (6.5)

1.34 (0.45, 4.00)

0.442

Discomfort

2 (3.8)

3 (6.5)

1.34 (0.45, 4.00)

0.442

8 (3.9, 71.0)
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Ibuki et al. conducted a case series to determine the effects of custom-made semi-rigid
foot orthoses alone and with rigid carbon fiber footplates on adults with midfoot OA.9 Subjects
were recruited through a private orthopedic foot and ankle clinic and were assessed by an
orthopedic surgeon.9 Subjects met inclusion criteria if they had a diagnosis of unilateral or
bilateral midfoot OA with radiographic evidence or had the presence of pain in the midfoot
region.9 Subjects were excluded if they had any other symptomatic conditions of their feet or
ankles unrelated to midfoot OA or if they previously received the same orthopedic treatment as
prescribed in this study, i.e. semi-rigid foot orthoses or carbon fiber footplates.9 A total of 57
subjects were included for analysis.9 All were fitted with custom-made semi-rigid foot orthoses
and 36 (63%) also had carbon fiber footplates modified into their footwear.9 Subjects were given
pre-treatment, 6-week, 12-week, and 24-week patient evaluation questionnaires.9 In order to
compare to other studies, this review focuses on the ‘average level of pain’ component of the
questionnaire pre-treatment and at 12 weeks. Table 4 shows a 1.61 mean reduction of the
patient’s baseline average pain. Researchers calculated a p-value of <0.01, which indicates a
statistically significant change from baseline.9 Researchers did not separate the data into foot
orthoses alone vs. foot orthoses and carbon fiber foot plates and stated a RCT would be
necessary to determine if the use of carbon fiber foot palates has any additional benefit to foot
orthoses alone.9 Ibuki et al. also did not mention any analysis compliance, tolerability or adverse
events.
Table 4. Subject’s “average level of pain” (0-10) score in Ibuki et al.9
Baseline Mean ± (SD)

4.70 ± (1.63)

12 weeks Mean ± (SD)

3.09 ± (1.85)

Mean change from baseline (Calculated)

-1.61

P-value

<0.01
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Chapman et al. conducted a double blind, two arm parallel group randomized controlled
trial to determine the effects of functional foot orthoses vs. sham control orthoses in adults with
midfoot OA.10 Participants were recruited at an outpatient clinic and included if they were ≥ 18
years of age, had diagnosed midfoot OA with radiographic evidence, or experienced midfoot
pain for ≥ 3 months.10 Subjects were excluded if they had a history of inflammatory joint disease,
neuropathy, stress fractures, lower limb surgery in the last year, or had existing use of OTC or
prescription foot orthoses.10 A total of 37 participants were randomized into the functional foot
orthoses group (n= 19) and sham orthoses control group (n=18).10 A total of 4 patients did not
complete the study giving an attrition rate of 11%.10 One discontinued the functional foot
orthoses due to pain related to the intervention.10 In the control group, one was lost to follow up
and two discontinued intervention due to pain unrelated to the sham orthoses.10 Chapman et al.
assessed subject’s average pain in the last month using an 11-point numeric rating scale scored
from ‘no pain’ to ‘pain as bad as you can imagine’ at baseline and 12 weeks.10 Table 5 illustrates
a mean change from baseline of patient’s “pain on average in last month” in both the functional
foot orthoses group (-1.6 ± 2.0) and the sham orthoses group (-1.2 ± 1.1).10 Researchers
calculated a mean difference of functional foot orthoses to sham orthoses is -0.4 (95% CI -1.60.8) indicating a wide estimate of treatment effect making it difficult to determine the efficacy of
both interventions. Chapman et al. also did not mention any analysis compliance, tolerability or
adverse events during this RCT.10
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Table 5. Subject’s “pain on average in last month” (0-11) score in Chapman et al.10
Functional Foot Orthoses (FFO) Group

Sham Orthoses Group

n = 19

n = 18

Baseline Mean ± (SD)

6.0 ± (1.6)

6.0 ± (1.9)

12 weeks Mean ± (SD)

4.3 ± (1.9)

4.5 ± (1.9)

Mean change from baseline ± (SD)

-1.6 ± (2.0)

-1.2 ± (1.1)

Mean difference of FFO-sham (95% CI)

-0.4 ± (-1.6 to 0.8)

DISCUSSION
Foot orthoses are commonly available in the United States, but the cost depends on
several factors such as if the orthoses are over the counter (OTC), non-prescription orthoses
made custom by do-it-yourself foot molds, or if a doctor prescribes them. Even when prescribed,
depending on the patient’s health insurance, foot orthoses are sometimes excluded from
coverage. According to CostHelper Health Incorporated, an online price quoting company, OTC
foot orthoses cost about $10-$80, about $100-$200 for non-prescription orthotics, and about
$200-$800 for prescription custom orthotics for uninsured patients and patients not covered by
health insurance.11
In terms of limitations of this review, when searching for randomized controlled trials
studying efficacy of foot orthoses for foot osteoarthritis, results were scarce. The study
conducted by Menz et al. was the first RCT to evaluate the effectiveness of mechanical
interventions in reducing foot pain in people with first MTP joint OA.8
In the study conducted by Menz et al., both interventions improved FHSQ pain scores.
Researchers thought it possible that the rocker-sole shoes have a potential for greater
effectiveness if barriers to adherence could be overcome.8 Since the orthoses group had higher
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adherence and lower rates of adverse events, researchers thought it may be the preferred
intervention.8 One major limitation of the study was that subjects were not blinded to the
intervention. Since subjects were recruited via radio, newspaper, and social media
advertisements and volunteered for the study, selection bias was introduced. As a result,
generalizability of the study is questionable.
In the case series conducted by Ibuki et al., researchers discussed that subjects who
received carbon fiber footplates in addition to functional orthoses did not seem to experience
greater relief than those who only received the functional orthoses, but a randomized controlled
trial would be needed to determine if the carbon fiber footplate has any additional benefits.9 A
major limitation of the Ibuki et al. case series was the lack of a control group. Researchers also
commented on the reliability and validity of the questionnaires utilized.9
In the randomized controlled trial conducted by Chapmen et al., researchers recognized
that future studies with more objective and sensitives measures should be utilized to detect
impairment and pain related function instead of subjective pain questionnaires.10 Researchers
also noted that they would recommend a trial including a third, active monitoring arm with no
planned treatment in order to better understand placebo effect.10
CONCLUSIONS
The two randomized controlled trials and one case series in this review showed some data
to suggest foot orthoses are effective at reducing pain in adults with foot osteoarthritis. However,
future randomized controlled trials are needed to determine if foot orthoses are superior to other
treatment options for foot OA. Though sample size and duration of treatment was sufficient for
the three studies in this review, randomized controlled trials with larger sample sizes, longer
duration, and third control arm with no planned treatment would benefit future studies.
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